© 2020 Akili
Teaches: Attention, memory, cognitive function, ADHD
An FDA approved prescription treatment video game for children with Attention Deficit Hyperactivity Disorder (ADHD) which is one of the most common psychiatric disorders in childhood. The leveled racing games are used to help children develop "attention and inhibitory contro...
An FDA approved prescription treatment video game for children with Attention Deficit Hyperactivity Disorder (ADHD) which is one of the most common psychiatric disorders in childhood. The leveled racing games are used to help children develop "attention and inhibitory controls." EndeavorRx is built on the "Selective Stimulus Management engine" (SSMETM) that "presents specific sensory stimuli and simultaneous motor challenges designed to target and activate the neural systems that play a key role in attention function while using adaptive algorithms to personalize the treatment experience for each individual patient." That might also be called classifying, and one might argue that a game of Sonic or Super Smash Bros. could have a similar outcome, but that's a matter of debate and the presentation of the memory tasks are much more controlled. What is not up for debate is that interactive media has been medically validated as a tool to alter behaviors; and that FDA certification will enable the publisher to market games like EndeavorRx through Doctor's offices backed by insurance plans. According to the publisher, the study effects considered 600 children diagnosed with ADHD, including a prospective, randomized, controlled study published in The Lancet Digital Health journal, which showed EndeavorRx improved objective measures of attention in children with ADHD. After four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention. Further, about half of parents saw a clinically meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx; this increased to 68% after a second month of treatment. Improvements in ADHD impairments following a month of treatment with EndeavorRx were maintained for up to a month. No serious adverse events have been associated with EndeavorRx in any study to date. Some study participants (9.3%) experienced non-serious treatment-related adverse events with EndeavorRx, including frustration, headache, dizziness, emotional reaction, nausea or aggression.